How does a stock that has less than 2 million in float trade over 10 million in two days? I'm pretty sure a dilution has already occurred and we are just waiting on the announcement. The company just gave the new investor enough time to create a pump and dump the shares at a profit before announcing that dilution occurred at $1.50 or so where it usually does when the stock is trading at $2. Then the stock falls to $1.40 overnight and trickles down below $1.00 where they do a reverse split and start the cycle all over again.
Management is corrupt and would do something like this so the company can get more money to pay high salaries. The stock was really $1400 about 6 years ago relative to today's $2 when you take into account how many times the company has followed this pattern of dilution. Think twice before being a long term investor. It's OK to try and ride a pump but stay away overnight because bad news for you may be coming. Shai will sell 4 times them amount of shares outstanding at a 30% or more discount. Crazy how this company stays in business. Probably the only company in history to loose 99.8% of an investors investment in a little over 6 years without bankruptcy because somehow they sucker more people in with their "high growth" prospects and great products. I bet Shai will be in jail someday for all the shadiness behind how his company stayed alive.
NURO finally has interest... I bet there is already a deal to dilute at 1.50 or so with options to buy more at 1.75. An I bet those individuals are already selling the shares into this rally. We will hear about it soon enough. the company needs more money to pay salaries. NURO is usually not one to hold overnight... buy I could be wrong. They could finally prove me wrong and actually let a run last a few days and dilute at much higher prices. Dilution is coming none the less it just depends on where. Hopefully they are nice to you shareholders and care a bit less about paying large salaries for years to come. I was a shareholder for part of today but don't dare hold overnight knowing management track records.
The easiest approach to targeting the prostate cancer is by inserting a probe through the rectum. The device uses ultra sound to detect the cancerous region and the image of the differentiated tissue including the cancer shows up on the screen. The doctor simply has to highlight the area on the computer screen where the cancer is and the robot does the rest. Using high frequency ultra sound waves the robot practically burns out the cancer killing the specific tissue leaving all other in tact in this non-invasive procedure. In most cases it takes care of the cancer and you are in remission which changes your life. The procedure costs about 25k. I hope that is a little clearer but its practically what I said before.
As of now the company may be deficient on their covenants after loosing their lawsuit and having to pay back years of royalties. The company is working with the banks but one of three things will happen from here. Most likely: Rearrangements on covenants
Possible: Bankruptcy and reorganization or dilution to bring finances back inline.
In bankruptcy shareholders would get little as creditors get paid first, then employees.
Watch for news how this settles and wait on the sidelines or chance loosing everything. If its Vegas money then do what you will.
We rate ALPHA PRO TECH LTD (APT) a BUY. This is driven by some important positives, which we believe
should have a greater impact than any weaknesses, and should give investors a better performance
opportunity than most stocks we cover. The company's strengths can be seen in multiple areas, such as its
revenue growth, largely solid financial position with reasonable debt levels by most measures, attractive
valuation levels, expanding profit margins and compelling growth in net income. Although no company is
perfect, currently we do not see any significant weaknesses which are likely to detract from the generally
The revenue growth came in higher than the industry average of 7.6%. Since the same quarter one year prior,
revenues rose by 18.2%. This growth in revenue appears to have trickled down to the company's bottom line,
improving the earnings per share.
APT has no debt to speak of therefore resulting in a debt-to-equity ratio of zero, which we consider to be a
relatively favorable sign. Along with this, the company maintains a quick ratio of 11.79, which clearly
demonstrates the ability to cover short-term cash needs
The company is increasing revenues, buying back stock, and doing all they need to except showing up to investor conferences and having more conference calls. A 52 week high could enlighten investors to the APT story which makes it a buy. Earnings will likely accelerate as sales do.
A 52 week high put us on radars. HD, Lowes, Builders, are all doing well and up 100% or so in the past year. APT supplies builders and should be far higher as well with the success the company is seeing in its building supply category. If we hit 1.95 I believe we could see 2.50 or more a week later.
Good question. EDAP is not the only player in the industry. EDAP is paying to get HIFU approved for prostate surgery here and then comes the other players and true realization. Play EDAP for a quick gain on US approval. Then expect it to fall when the EDAP has to compete with new entrants. HIFU for prostate is approved elsewhere. If EDAP was so good they would be making money now in those countries. You will make money buying EDAP here but you will loose everything you gained if you wait too long to sell. CanSlim showed a buy sign yesterday. EDAP is nothing more than a trade.
This is the current policy in france. The new policy appears to significantly limit coverage and reimbursement of the use of HIFU in the treatment of prostate cancer to patients in one or other of two groups:
Patients with localized prostate cancer requiring first-line therapy “who cannot undergo surgery or radiotherapy”
Patients with recurrence of their prostate cancer after radiotherapy
The reimbursement policy being put in place also seems to require that HIFU centers in France will receive reimbursement only if they contribute predefined data to a dedicated HIFU registry for the next 5 years.
Listen to the renshaw conference. Don't fool yourself if you think a decision will come earlier than the own company says it will. They are getting ready to sell in the US if a good decision is made. Each device costs in the high 600 thousands. EDAPs market cap could almost buy you 100 of their machines. Listen to the conference before getting overly exuberant like some on this board. The technology sounds impressive but its not the cure for all prostate cancers. EDAPs working on patents since the company knows it wont be the only player. Hifu would change the course of normal treatment for candidates. To increase the market EDAP is working in Europe to get approval pancreatic and other cancers.
The key to the struggles EDAP has now with making money is the cost of the machine and lack of insurance coverage. They don't even have coverage in France. Step one is getting approval step two is getting insurance coverage. Id like to see the company making money and getting coverage in their hone country is a first step id like to see. It sounds like the company thinks this will be soon. Insurances rule the US and obambacare will put things further into their hands. Insurance coverage makes or breaks companies and new procedures are not looked at kindly by obamas campaign funding insurance friends.
There is a higher power involved with EDAP. It is definitely manipulation but the reason might be good or bad. We have someone adding to their position on select days waiting for approval or someone trading between accounts (illegally but can be done) on select days trying to induce the CanSlim buy signal. I'm thinking that we see a more powerful aftershock after a few days of nothing. I think last week was only the beginning of another move like the one that took us to almost 5.
EDAP management has just gotten sick of the the system. There is a general guideline for time-frame of a decision but that is it. EDAP is sick of being wrong and they are the ones that chose to just say the truth that no-one really ever knows and its just an expected time-frame. We can still expect sometime early next year for a decision. Most likely that will be yes and the stock will trade up to 8 bucks or so on the announcement. Anyone sticking around talking down the company wants to get the stock as low as possible to get cheap shares or is just insane if short and are hoping on a negative decision. Robotics in medicine are hot stuff right about now. If I were the company, I would be talking about robotic use and HIFU around the leaving the US decision out of things right now except to say that they are in the process of getting clearance.
Lets see where we go but most of my position is gone. Irrational exuberance took over this stock. I think its worth over ten but not this year with expected earnings. I'm buying NVTL with some of my profits and betting on an undervalued M2M stock.
It won't but it will by the end of the year and possibly much more. In a way I am glad. I have some money coming free tomorrow. The building industry is hot and it trickles down to APT. The flu season is also coming along. Perfect storm of things that can take APT above five like a few years back.
Nurometrix drops products like Shai does old boyfriends. Today Sensus is the reason NURO is going to make you a fortune and tomorrow you wont even hear about it. Execs get paid way too much and the company still finds new ways to draw suckers in to PIPES. If it was not for dilution this company would have been bankrupt a long time ago. The real suckers are any longs and I was one of them. If you have been holding for years and looked at your account you might just think that they did go bankrupt. NURO is almost not even a good trade since Shai and Co. are so quick to raise cash. Last time the stock jumped and looked like it had any life that turd raised cash the very next day at a huge discount.
Others will follow allowing a premium in the stocks like GTAT that help increase capacity.
We knew it was coming but news like this is finally here. Big News... look at the SPWR release.
When 2005 comes Ballard will be pushing 10 and you will all wonder why you did not throw the house at it. Dumb move to get to big of a position in anything so don't do it. I wish I still had my 5000 shares of KMX I bought at 1.05 or 3000 of LF at bought at 1.20. I took a 100% gain after months/years of waiting in both and missed out on a whole lot of gains left in the tank.
No need for cash. Warrants will bring in extra money and it looks like this runup will wash all those out which have been a nuisance to any sustained rally.